Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Department of Internal Medicine - Nephrology,
Einthoven Laboratory of Vascular and Regenerative Medicine
Franck Lebrin has not added Biography.
If you are Franck Lebrin and would like to personalize this page please email our Author Liaison for assistance.
ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis.
PloS one , 2014 | Pubmed ID: 24489709
Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous Malformations.
Arteriosclerosis, thrombosis, and vascular biology Apr, 2016 | Pubmed ID: 26821948
A New Wnt1-CRE Tomato Embryonic Stem Cell Line: A Tool for Studying Neural Crest Cell Integration Capacity.
Stem cells and development Dec, 2017 | Pubmed ID: 28922973
Executive summary of the 12th HHT international scientific conference.
Angiogenesis Feb, 2018 | Pubmed ID: 29147802
Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2.
Circulation 12, 2018 | Pubmed ID: 30571259
Pericytes in Hereditary Hemorrhagic Telangiectasia.
Advances in experimental medicine and biology , 2019 | Pubmed ID: 31147880
Glomerular Function and Structural Integrity Depend on Hyaluronan Synthesis by Glomerular Endothelium.
Journal of the American Society of Nephrology : JASN Oct, 2019 | Pubmed ID: 31308073
Endothelial Zeb2 preserves the hepatic angioarchitecture and protects against liver fibrosis.
Cardiovascular research Apr, 2021 | Pubmed ID: 33909875
Imaging the Renal Microcirculation in Cell Therapy.
Cells May, 2021 | Pubmed ID: 34063200
Thresholds of Endoglin Expression in Endothelial Cells Explains Vascular Etiology in Hereditary Hemorrhagic Telangiectasia Type 1.
International journal of molecular sciences Aug, 2021 | Pubmed ID: 34445652
Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip.
Stem cell reports Jul, 2022 | Pubmed ID: 35777360
Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study.
Journal of clinical medicine Sep, 2022 | Pubmed ID: 36142926
Leiden University Medical Center
Institute Physics for Medicine Paris, Inserm, ESPCI-Paris-PSL
Katerina Stripling1,2,
Finn Timmermans1,2,
Sofiane Décombas-Deschamps3,
Jérémy H. Thalgott1,2,
David Lemonnier1,2,3,
Margreet R. de Vries2,4,5,
Ton J. Rabelink1,2,6,
Mickael Tanter3,
Thomas Deffieux3,
Franck Lebrin1,2,3
1Department of Internal Medicine - Nephrology, Leiden University Medical Center,
2Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center,
3, Institute Physics for Medicine Paris, Inserm, ESPCI-Paris-PSL,
4Department of Surgery - Vascular surgery, Leiden University Medical Center,
5Department of Surgery, Brigham & Women's Hospital, Harvard Medical School,
6The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden University Medical Center
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved